ProgenaBiome

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Nov 5, 2026

No longer available

Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder

Nov 5, 2026

No longer available

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

Nov 5, 2026

Completed

A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection

Earlier

Oct 10, 2026TrialAn Open-Label Phase I Clinical Trial of Vancomycin Followed by Fecal Microbiota Transplant for the Treatment of Parkinson's Disease

Sep 22, 2026TrialA Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Sep 22, 2026TrialA Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection

Sep 19, 2026TrialAn Open-Label Phase I Clinical Trial of Vancomycin Followed by Familial Fecal Microbiota Transplant in Adult Subjects With Autism Spectrum Disorder (ASD)

Dec 9, 2020TrialTrial of Combination Therapy to Treat COVID-19 Infection

4 more events

Jul 1, 2020TrialA Study of Combination Therapies to Treat COVID-19 Infection

Jun 22, 2020TrialA Study of Quintuple Therapy to Treat COVID-19 Infection

Jan 1, 2020TrialA Study of ResCure™ to Treat COVID-19 Infection

Sep 18, 2018TrialA Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)